Evidence map›Paper›PMID 37404730›Full record

ArticleFrontiers in cardiovascular medicine2023

Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements.

Alexander Vogt, Jochen Dutzmann, Michael Nußbaum, Daniel Hoyer, Jörn Tongers, Axel Schlitt, Daniel Sedding, Alexander Plehn

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Renal Denervation in Cardiovascular Diseases: Mechanisms, Evidence, and Expanding Applications.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Review
  3. Article
  4. Review
  5. A preclinical study of combined hepatic and renal artery denervation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Inflammatory Biomarkers in Hypertension.Current medicinal chemistry · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Effects of renal denervation on the incidence and severity of cardiovascular diseases.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alexander VogtDepartment of Internal Medicine III, University Hospital Halle (Saale), Halle (Saale), Germany.
Jochen DutzmannDepartment of Internal Medicine III, University Hospital Halle (Saale), Halle (Saale), Germany.
Michael NußbaumDepartment of Internal Medicine III, University Hospital Halle (Saale), Halle (Saale), Germany.
Daniel HoyerDepartment of Internal Medicine III, University Hospital Halle (Saale), Halle (Saale), Germany.
Jörn TongersDepartment of Internal Medicine III, University Hospital Halle (Saale), Halle (Saale), Germany.
Axel SchlittDepartment of Cardiology and Diabetes, Paracelsus-Harz-Clinic Bad Suderode, Quedlinburg, Germany.
Daniel SeddingDepartment of Internal Medicine III, University Hospital Halle (Saale), Halle (Saale), Germany.
Alexander PlehnDepartment of Internal Medicine III, University Hospital Halle (Saale), Halle (Saale), Germany.
University Hospital in Halle · DEOrthopädische Praxis · DEParacelsus-Harz-Klinik Bad Suderode · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Renal sympathetic denervation (RDN) has been shown to lower arterial blood pressure both in the presence and in the absence of antihypertensive medication in an observation period of up to 3 years. However, long-term results beyond 3 years are scarcely reported. Methods: We performed a long-term follow-up on patients who were previously enrolled in a local renal denervation registry and who underwent radiofrequency RDN with the Symplicity Flex® renal denervation system between 2011 and 2014. The patients were assessed to evaluate their renal function by performing 24-hour ambulatory blood pressure measurement (ABPM), recording their medical history, and conducting laboratory tests. Results: Ambulatory blood pressure readings for 24 h were available for 72 patients at long-term follow-up (FU) [9.3 years (IQR: 8.5-10.1)]. We found a significant reduction of ABP from 150.1/86.1 ± 16.9/12.0 mmHg at baseline to 138.3/77.1 ± 16.5/11.1 mmHg at long-term FU ( Conclusions: RDN was accompanied by a long-lasting reduction in blood pressure with a concomitant reduction in antihypertensive medication. No negative effects could be detected, especially with regard to renal function.

Indexed as

ambulatory blood pressurelong-term effectrenal denervation (RDN)renal functionuncontrolled hypertension

Identifiers

PMID37404730
PMCPMC10315532
OpenAlexW4381149175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.